The rate of trachoma, or ocular chlamydia, among children living in hyperendemic areas can be stalled with annual or biannual mass azithromycin distribution. However, discontinuing the antibiotic after 4 years led to an increased rate of infection in the pediatric population, according to trial results published in PLoS Medicine.
“WHO recommends annual mass azithromycin administration in communities with at least 10% prevalence of trachomatous inflammation-follicular, or TF, in children, with further treatment depending on reassessment after 3 to 5 years,” Jeremy D. Keenan, MD, a professor at the University of California, San Francisco’s Proctor Foundation and an ophthalmologist with UCSF Health, and colleagues wrote. “However, the effect of stopping mass azithromycin distribution after multiple rounds of treatment is not well understood.”
AKH Inc., Advancing Knowledge in Healthcare and Psychiatric Annals
American Academy of Pediatrics National Conference & Exhibition
Search Healio's robust listing of national and international medical meetings.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2018 Healio All Rights Reserved.